<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">phkinetica-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ФАРМАКОДИНАМИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL PHARMACODYNAMICS STUDIES</subject></subj-group></article-categories><title-group><article-title>Эффективность аскорбата лития на модели хронической алкогольной интоксикации</article-title><trans-title-group xml:lang="en"><trans-title>The effectiveness of lithium ascorbate on chronic alcohol intoxication model</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Остренко</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostrenko</surname><given-names>K. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>Ольга Алексеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сардарян</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sardaryan</surname><given-names>I. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демидов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Demidov</surname><given-names>V. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жидоморов</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhidomorov</surname><given-names>N. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пронин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pronin</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривоногов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Krivonogov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпунина</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpunina</surname><given-names>Yu. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «ВНИИ физиологии, биохимии и питания животных»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FGBNU «Institute of Physiology, Biochemistry and Nutrition of Animals»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановская государственная медицинская академия»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>«Ivanovo State Medical Academy»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВПО «Санкт-Петербургский государственный педиатрический медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FFSBI HPE «Saint Petersburg State Pediatric Medical University» of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО «Московский физико-технический институт (государственный университет)»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Institute of Physics and Technology (State University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2017</year></pub-date><volume>0</volume><issue>1</issue><fpage>11</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Остренко К.В., Громова О.А., Сардарян И.С., Демидов В.И., Жидоморов Н.Ю., Торшин И.Ю., Пронин А.В., Кривоногов В.А., Карпунина Ю.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Остренко К.В., Громова О.А., Сардарян И.С., Демидов В.И., Жидоморов Н.Ю., Торшин И.Ю., Пронин А.В., Кривоногов В.А., Карпунина Ю.В.</copyright-holder><copyright-holder xml:lang="en">Ostrenko K.V., Gromova O.A., Sardaryan I.S., Demidov V.I., Zhidomorov N.Y., Torshin I.Y., Pronin A.V., Krivonogov V.A., Karpunina Y.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/4">https://www.pharmacokinetica.ru/jour/article/view/4</self-uri><abstract><p>Исследовано действие аскорбата лития на модели хронической алкогольной интоксикации. Воздействие алкоголя приводит к возникновению девиантного поведения у животных, повышает агрессию и вызывает необратимые дегенеративные изменения в печени и ЦНС. Аскорбат лития в дозе 5 мг/кг, как и в более высоких дозах (10 и 30 мг/кг), активирует адаптивные механизмы, нормализуя поведенческие реакции в тестах «открытое поле» и «приподнятый крестообразный лабиринт». Гистологический анализ показал, что использование аскорбата лития минимизировало уровень ишемического повреждения нейроцитов до уровня обратимого состояния. В целом, применение аскорбата лития способствует купированию абстинентного синдрома, блокирует возникновение судорог и способствует сохранности функции ЦНС в модели хронической алкогольной интоксикации.</p></abstract><trans-abstract xml:lang="en"><p>The alcohol leads to deviant behavior in animals, increases aggression and irreversible degenerative changes in the liver and in the central nervous system. Lithium ascorbate in dose of 5 mg/kg, as well as higher doses (10 and 30 mg/kg), activates adaptive mechanisms normalizing behavioral responses in the tests «open field» and «elevated plus-maze». Histological analysis showed that lithium ascorbate minimize ischemic damage of neurocytes to a reversible state. In general, the use of lithium ascorbate contributes to relief of withdrawal symptoms, inhibited the occurrence of seizures and contributed to preservation of the function of the central nervous system in the model of chronic alcohol intoxication.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>алкогольная интоксикация</kwd><kwd>аскорбат лития</kwd><kwd>нормотим</kwd><kwd>alcohol intoxication</kwd><kwd>lithium ascorbate</kwd><kwd>Normotim</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Myers R.D., McMillen B.A., Adell A. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism: Epitome of cerebral complexity. Neurochem. Int. 1995; 26: 337.</mixed-citation><mixed-citation xml:lang="en">Myers R.D., McMillen B.A., Adell A. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism: Epitome of cerebral complexity. Neurochem. Int. 1995; 26: 337.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Darcq E., Warnault V., Phamluong K., Besserer G.M., Liu F., Ron D. MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption. Mol. Psychiatry. 2014 Oct 21.</mixed-citation><mixed-citation xml:lang="en">Darcq E., Warnault V., Phamluong K., Besserer G.M., Liu F., Ron D. MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption. Mol. Psychiatry. 2014 Oct 21.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chang C.M., Wu C.S, Huang Y.W., Chau Y.L., Tsai H.J. Utilization of Psychopharmacological Treatment Among Patients With N ewly Diagnosed Bipolar Disorder From 2001 to 2010. J Clin Psychopharmacol. 2016; 36 (1): 32-44 doi.</mixed-citation><mixed-citation xml:lang="en">Chang C.M., Wu C.S, Huang Y.W., Chau Y.L., Tsai H.J. Utilization of Psychopharmacological Treatment Among Patients With N ewly Diagnosed Bipolar Disorder From 2001 to 2010. J Clin Psychopharmacol. 2016; 36 (1): 32-44 doi.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zawalich W.S., Zawalich K.C., Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perifused rat islets. Biochem J. 1989; 262 (2): 557-561.</mixed-citation><mixed-citation xml:lang="en">Zawalich W.S., Zawalich K.C., Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perifused rat islets. Biochem J. 1989; 262 (2): 557-561.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz-Sastre C., Perez-Rodriguez M.M., Cebollada A., Ruiz J.S., Baca-Garcia E., de Leon J. Cholesterol and lithium levels were correlated but serum HDL and total cholesterol levels were not associated with current mood state in bipolar patients. J Clin Psychiatry. 2005; 66 (3): 399-400.</mixed-citation><mixed-citation xml:lang="en">Diaz-Sastre C., Perez-Rodriguez M.M., Cebollada A., Ruiz J.S., Baca-Garcia E., de Leon J. Cholesterol and lithium levels were correlated but serum HDL and total cholesterol levels were not associated with current mood state in bipolar patients. J Clin Psychiatry. 2005; 66 (3): 399-400.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Koda L.Y., Shoemaker W.J., Baetge G., Bloom F.E. Lithium treatment decreases blood pressure in genetically hypertensive rats. Eur J Pharmacol. 1981; 76 (4): 411-415.</mixed-citation><mixed-citation xml:lang="en">Koda L.Y., Shoemaker W.J., Baetge G., Bloom F.E. Lithium treatment decreases blood pressure in genetically hypertensive rats. Eur J Pharmacol. 1981; 76 (4): 411-415.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Focosi D., Azzara A., Kast R.E., Carulli G., Petrini M. Lithium and hematology: established and proposed uses. J Leukoc Biol. 2009; 85 (1): 20-8 doi.</mixed-citation><mixed-citation xml:lang="en">Focosi D., Azzara A., Kast R.E., Carulli G., Petrini M. Lithium and hematology: established and proposed uses. J Leukoc Biol. 2009; 85 (1): 20-8 doi.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Phelan K.M., Mosholder A.D., Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry. 2003; 64 (11): 1328-1334.</mixed-citation><mixed-citation xml:lang="en">Phelan K.M., Mosholder A.D., Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry. 2003; 64 (11): 1328-1334.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hillert M.H., Imran I., Zimmermann M., Lau H., Weinfurter S., Klein J. Dynamics of hippocampal acetylcholine release during lithium-pilocarpine-induced status epilepticus in rats. J Neurochem. 2014; 131 (1): 42-52 doi.</mixed-citation><mixed-citation xml:lang="en">Hillert M.H., Imran I., Zimmermann M., Lau H., Weinfurter S., Klein J. Dynamics of hippocampal acetylcholine release during lithium-pilocarpine-induced status epilepticus in rats. J Neurochem. 2014; 131 (1): 42-52 doi.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Stengaard-Pedersen K., Schou M. In vitro and in vivo inhibition by lithium of enkephalin binding to opiate receptors in rat brain. Neuro-pharmacology. 1982; 21 (8): 817-823.</mixed-citation><mixed-citation xml:lang="en">Stengaard-Pedersen K., Schou M. In vitro and in vivo inhibition by lithium of enkephalin binding to opiate receptors in rat brain. Neuro-pharmacology. 1982; 21 (8): 817-823.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ebstein R.P., Hermoni M., Belmaker R.H. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther. 1980; 213 (1): 161-167.</mixed-citation><mixed-citation xml:lang="en">Ebstein R.P., Hermoni M., Belmaker R.H. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther. 1980; 213 (1): 161-167.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Basselin M., Chang L., Bell J.M., Rapoport S.I. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacol 2005; 30 (6):1064-1075.</mixed-citation><mixed-citation xml:lang="en">Basselin M., Chang L., Bell J.M., Rapoport S.I. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacol 2005; 30 (6):1064-1075.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Castro L., Athanazio R., Barbetta M., Ramos A.C., Angelo A.L., Campos I., Varjao B., Ferreira H., Fregoneze J., de Castro e Silva E. Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats. Brain Res. 2003; 981 (1-2):151-159.</mixed-citation><mixed-citation xml:lang="en">Castro L., Athanazio R., Barbetta M., Ramos A.C., Angelo A.L., Campos I., Varjao B., Ferreira H., Fregoneze J., de Castro e Silva E. Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats. Brain Res. 2003; 981 (1-2):151-159.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Basselin M., Chang L., Bell J.M., Rapoport S.I. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacol. 2006; 31 (8): 1659-74 Epub 2005 N.</mixed-citation><mixed-citation xml:lang="en">Basselin M., Chang L., Bell J.M., Rapoport S.I. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacol. 2006; 31 (8): 1659-74 Epub 2005 N.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Marx C.E., Yuan P., Kilts J.D., Madison R.D., Shampine L.J., Manji H.K. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol 2008; 11 (4): 547-52 doi.</mixed-citation><mixed-citation xml:lang="en">Marx C.E., Yuan P., Kilts J.D., Madison R.D., Shampine L.J., Manji H.K. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol 2008; 11 (4): 547-52 doi.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Сардарян И.С., Громова О.А., Расташанский В.А., Федотова Л.Э. Хемореактомное моделирование аскорбата лития. Фармакокинетика и фармакодинамика, 2016; 3: 47-58.</mixed-citation><mixed-citation xml:lang="en">Торшин И.Ю., Сардарян И.С., Громова О.А., Расташанский В.А., Федотова Л.Э. Хемореактомное моделирование аскорбата лития. Фармакокинетика и фармакодинамика, 2016; 3: 47-58.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mihara M., Uchiyama M. Biochemistry. N.Y.: Med, 1980; 23: 302.</mixed-citation><mixed-citation xml:lang="en">Mihara M., Uchiyama M. Biochemistry. N.Y.: Med, 1980; 23: 302.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Бочкарева А.В., Зимин Ю.В. Изменение активности алкоголь-дегидрогеназы клеток печени крыс при действии этанола и гепарина. Вестник Нижегородского университета им. Н.И. Лобачевского, 2010; 2 (2): 490-493.</mixed-citation><mixed-citation xml:lang="en">Бочкарева А.В., Зимин Ю.В. Изменение активности алкоголь-дегидрогеназы клеток печени крыс при действии этанола и гепарина. Вестник Нижегородского университета им. Н.И. Лобачевского, 2010; 2 (2): 490-493.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Шабанов П.Д., Калишевич С.Ю. Биология алкоголизма. СПб.: 1998; 272.</mixed-citation><mixed-citation xml:lang="en">Шабанов П.Д., Калишевич С.Ю. Биология алкоголизма. СПб.: 1998; 272.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
